SOXX vs XBI
iShares Semiconductor ETF vs SPDR S&P Biotech ETF
- • SOXX has the lower expense ratio at 0.33% vs 0.35% for XBI.
- • XBI pays a higher dividend yield (0.35%).
Side-by-side metrics
| Metric | SOXX | XBI |
|---|---|---|
Expense ratio Annual fee. Lower is better. | 0.33% | 0.35% |
Dividend yield Trailing 12-month yield. | 0.27% | 0.35% |
AUM Assets under management — bigger funds are typically more liquid. | $43.67B | $10.92B |
YTD return | 46.45% | 28.80% |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | 2.41 | 1.01 |
P/E ratio | 33.43 | — |
Last price | $157.94 | $156.41 |
Inception | — | — |
Issuer | iShares | State Street |
SOXX top holdings
| AMD | Advanced Micro Devices Inc | 9.24% |
| NVDA | NVIDIA Corp | 7.98% |
| MU | Micron Technology Inc | 7.95% |
| AVGO | Broadcom Inc | 7.58% |
| INTC | Intel Corp | 6.33% |
| TXN | Texas Instruments Inc | 4.96% |
| ADI | Analog Devices Inc | 4.96% |
| QCOM | Qualcomm Inc | 4.16% |
| MRVL | Marvell Technology Inc | 4.00% |
| KLAC | KLA Corp | 3.88% |
XBI top holdings
| MRNA | Moderna Inc | 2.37% |
| NTRA | Natera Inc | 1.82% |
| HALO | Halozyme Therapeutics Inc | 1.77% |
| TWST | Twist Bioscience Corp | 1.77% |
| BIIB | Biogen Inc | 1.75% |
| AMGN | Amgen Inc | 1.73% |
| EXEL | Exelixis Inc | 1.73% |
| UTHR | United Therapeutics Corp | 1.72% |
| ABBV | AbbVie Inc | 1.71% |
| GILD | Gilead Sciences Inc | 1.70% |
About SOXX
SOXX (iShares Semiconductor ETF) is US semiconductor equities. Managed by iShares, the fund carries $43.7B in assets under management, an expense ratio of 0.33%, a dividend yield of 0.27%. Its largest holding is Advanced Micro Devices Inc (AMD), which represents 9.2% of the portfolio. Technology is the fund's largest sector exposure at 100.0%.
About XBI
XBI (SPDR S&P Biotech ETF) is Equal-weight biotech stocks in the S&P Biotech Index. Managed by State Street, the fund carries $10.9B in assets under management, an expense ratio of 0.35%, a dividend yield of 0.35%. Its largest holding is Moderna Inc (MRNA), which represents 2.4% of the portfolio. Financial Services is the fund's largest sector exposure at 0.6%.